Cargando…

Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma

INTRODUCTION: The clinical significance, biological roles and potential mechanism of Rab18 remain unknown in most human cancers, including head and neck squamous cell carcinoma (HNSCC). METHODS: We used immunohistochemistry to examine Rab18 protein expression in 112 cases of HNSCC specimens. We over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Xu, Guo, Xing, Wang, Yan, Li, Xiaotian, Li, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231766/ https://www.ncbi.nlm.nih.gov/pubmed/32494165 http://dx.doi.org/10.2147/OTT.S238503

Ejemplares similares

S-nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma()
por: Kaliyaperumal, Kolanjiappan, et al.
Publicado: (2015)

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
por: Henriksson, Eva, et al.
Publicado: (2009)

DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2013)

MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma
por: Sheng, Shuyan, et al.
Publicado: (2022)

Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)
por: Zhang, Fugui, et al.
Publicado: (2017)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

Lycopene inhibits the cell proliferation and invasion of human head and neck squamous cell carcinoma
por: Ye, Min, et al.
Publicado: (2016)

CCR7 Regulates Cell Migration and Invasion through JAK2/STAT3 in Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Liu, Fa-Yu, et al.
Publicado: (2014)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A
por: Chen, Qi, et al.
Publicado: (2019)

AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway
por: Chang, Wei-Min, et al.
Publicado: (2019)

Eligibility criteria to cisplatin in head and neck squamous cell carcinoma: Egyptian expert opinion
por: Abdulla, Mohamed, et al.
Publicado: (2023)

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)

EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells
por: Grandits, Alexander Michael, et al.
Publicado: (2022)

Mining database for the expression and clinical significance of STAT family in head and neck squamous cell carcinomas
por: Ni, Haosheng, et al.
Publicado: (2020)

Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma
por: Fan, Teng-Fei, et al.
Publicado: (2016)

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
por: Liu, Shutong, et al.
Publicado: (2017)

5-Methoxytryptophan Sensitizing Head and Neck Squamous Carcinoma Cell to Cisplatitn Through Inhibiting Signal Transducer and Activator of Transcription 3 (STAT3)
por: Su, Yu-Chieh, et al.
Publicado: (2022)

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2016)

Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD‐L1
por: Zhang, Pei, et al.
Publicado: (2018)

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling
por: Fu, Lin, et al.
Publicado: (2021)

Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25
por: Wang, Xueping, et al.
Publicado: (2021)

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
por: Peyser, Noah D., et al.
Publicado: (2015)

Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
por: Tahara, Makoto, et al.
Publicado: (2014)

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
por: Trieu, Vanessa, et al.
Publicado: (2018)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

PLAU1 Facilitated Proliferation, Invasion, and Metastasis via Interaction With MMP1 in Head and Neck Squamous Carcinoma
por: Wu, Kun, et al.
Publicado: (2021)

MicroRNAs and cell proliferation in head and neck squamous cell carcinoma
por: Andreghetto, Flavia M, et al.
Publicado: (2013)

The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin
por: Bostan, Marinela, et al.
Publicado: (2020)

Knockdown of LncRNA RHPN1-AS1 Inhibits Cell Migration, Invasion and Proliferation in Head and Neck Squamous Cell Carcinoma
por: Qiu, Xiaowen, et al.
Publicado: (2019)

Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2019)

Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2015)

The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2020)

High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma
por: Téllez-Gabriel, Marta, et al.
Publicado: (2013)

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)()
por: Almeida, Luciana O., et al.
Publicado: (2013)

NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment
por: Wang, Yi-Fen, et al.
Publicado: (2014)

Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion
por: Sarnella, Annachiara, et al.
Publicado: (2022)

Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
por: Hurník, Pavel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_95io8js89fas010mq3buh8tvug